(Q38988778)

8 September 2017

Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo (English)

1 reference

8 September 2017

Zhao Hao

1

1 reference

8 September 2017

Wei Fan

2

1 reference

8 September 2017

Jian Hao

3

1 reference

8 September 2017

Xin Wu

4

1 reference

8 September 2017

Guo Qing Zeng

5

1 reference

8 September 2017

Li Juan Zhang

6

1 reference

8 September 2017

Sui Feng Nie

7

1 reference

8 September 2017

Xu Dong Wang

8

1 reference

8 September 2017

language of work or name

English

0 references

publication date

3 June 2014

1 reference

8 September 2017

1 reference

8 September 2017

23

1 reference

8 September 2017

3

1 reference

8 September 2017

874-881

1 reference

Creative Commons Attribution 4.0 International

8 September 2017

start time

3 June 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Prostate cancer bone metastases promote both osteolytic and osteoblastic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Atelocollagen for protein and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Monoclonal antibodies to CNA, a collagen-binding microbial surface component recognizing adhesive matrix molecules, detach Staphylococcus aureus from a collagen substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.920059

10.3109/10717544.2014.920059

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference